
About Ossium Health
Ossium Health is a Healthcare company based in San Francisco (United States) founded in 2016 by Kevin Caldwell and Erik Woods. Ossium Health is focused on bioengineering for improved health. It operates on a HealthTech and Professional Services model. Ossium Health has raised $125.41 million across 12 funding rounds from investors including HHS, Computer Programs Marketing Group and Vivo Capital. Its chief executive, as recorded, is Kevin Caldwell. Ossium Health offers products and services including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments. Its focus areas include Biotechnology and Cell Therapy. Its legal entity is Ossium Health, Inc. Its competitors include Cellino, Adicet Bio and Orca Bio; 3 of its 3 listed competitors have raised funding.
Company details
Ossium Health is engaged in bioengineering to enhance human health, vitality, and longevity. The company is recognized for creating a new paradigm in cell therapy by utilizing deceased donor transplant ecosystems to combat blood and immune system diseases. Solutions are developed for hematologic diseases, organ transplant rejection, and orthopedic applications. Partnerships are established with healthcare providers, life science companies, and organ procurement organizations to advance and deploy innovative cell therapies.
- Headquarters San Francisco, United States
- Founders Kevin Caldwell, Erik Woods
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ossiumhealth.com
- Social LinkedIn X
- Legal Name Ossium Health, Inc.
- Total Equity Funding$125.41M (USD)
in 12 rounds
- Latest Funding Round$375.11K (USD), Grant
Aug 2024
- InvestorsHHS
& 8 more
Products & Services of Ossium Health
Ossium Health offers a comprehensive portfolio of products and services, including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.
Stem cells are developed for blood disease treatment.
Solutions are provided to prevent organ transplant rejection.
Treatments are offered for orthopedic health and recovery.
Funding Insights of Ossium Health
Ossium Health has successfully raised a total of $125.41M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $375.11 thousand completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $125.41M
- Total Rounds 12
- Last Round Grant β $375,113
- Investors Count 9
Latest 10 of 12 funding rounds of Ossium Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $375,113 | Grant | β | β | |
| Jul 2023 | $52M | Series C | β | CPMG | |
| Apr 2023 | $3.46M | Grant | β | β | β |
| Sep 2021 | $361,553 | Grant | β | β | |
| Mar 2021 | $63M | Series B | β | General Catalyst, Vivo Capital | |
| Aug 2020 | $299,998 | Grant | β | β | |
| Jul 2020 | $299,950 | Grant | β | β | |
| May 2018 | $10.41M | Series A | β | β | β |
| Mar 2018 | $1.68M | Grant | β | β | |
| Jul 2017 | $239,080 | Grant | β | β |
9 investors in total: 8 institutional and 1 angel.
Investors in Ossium Health
Ossium Health has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Computer Programs Marketing Group and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
US focused seed and early-stage VC firm | firstround.com | San Francisco, United States | ||
Early-stage ventures are targeted for investment by this VC fund. | mantaray.vc | London, United Kingdom | ||
Venture capital investing and portfolio management services for accredited investors. | av.vc | |||
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Investments in early-stage companies are managed by XYZ Venture Capital. | xyz.vc | San Francisco, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Software solutions for mainframe platforms are provided by the company. | 1993 | cpmg.com | Montague, United States | |
AK Asahi Kasei | unknown_0f49936f6341465f8 |
Investor details for Ossium Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ossium Health
40 people are tracked at Ossium Health (12 in leadership, 28 in team).
| Name | Role | Group |
|---|---|---|
Kevin Caldwell | Co-Founder & CEO | Leadership |
Erik Woods | Co-Founder & CSO | Leadership |
Brian Johnstone | VP of Research | Leadership |
W. Scott Goebel | Medical Director | Leadership |
Sagar Munjal | Chief Medical Officer & SVP | Leadership |
Nick Niehaus | Senior Director, Accounting (controller) | Leadership |
Kelsey Musall | Director, Clinical Production | Leadership |
Wa'el Al Rawashdeh | Director, Development | Leadership |
Chip Walker-Wilson | VP of Legal | Leadership |
Ed Jun | Vice President Finance | Leadership |
Brian Legg | Facility Director | Leadership |
Aubrey Sherry | Director, Quality Assurance | Leadership |
Melany Magrone | Manager, Donor Services | Team |
Michael Blue | Senior Material Handler | Team |
Kevin Blankenberger | Quality Control Associate III & CLIA General Supervisor | Team |
Kerry Gray | Cell Therapy Associate II, Clinical Production | Team |
Nick Weinstein | Floor Supervisor, Clinical Production | Team |
Elisa Hartman | Cell Therapy Associate II, Clinical Production | Team |
Tyler Hoodlebrink | Cell Therapy Associate II, Clinical Production | Team |
Winston Woodfork | Cell Therapy Associate II, Clinical Production | Team |
20 more people are available in the full profile.
Complete people profiles for Ossium Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ossium Health
3 dated milestones of Ossium Health across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Ossium Health is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $375K.
Competitors of Ossium Health
Ossium Health has 3 listed competitors in our database, 3 of them funded. They include Cellino, Adicet Bio and Orca Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies | |
| adicetbio.com | 2014 | Menlo Park, United States | $51M | 86 | Immune cell therapies for cancer treatment are developed. | |
| orcabio.com | 2016 | Menlo Park, United States | $300M | 66 | Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders |
Detailed competitors of Ossium Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ossium Health
The website of Ossium Health (ossiumhealth.com) receives about 7.5K visits a month.
- Monthly visits7.5K
▲ 129.5% vs previous month
Websites whose visitors overlap most with Ossium Health. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| r2mpharma.com | 100% | 2.9K | #4,331,217 | View details | |
| quantatx.com | 100% | 3.1K | #5,909,422 | View details | |
| astellasgenetherapies.com | 99% | 1K | View details | ||
| excision.bio | 97% | 2.4K | #7,581,873 | View details | |
| aligos.com | 97% | 3.4K | #3,982,602 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 34 similar websites and full traffic analytics for Ossium Health
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 34 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Ossium Health (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ossium Health
Complete news archive for Ossium Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ossium Health
Ossium Health was founded in 2016.
Ossium Health is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Kevin Caldwell is the CEO of Ossium Health, as recorded in our data. They have also founded this company.
Ossium Health is a funded company, having raised a total of $125.41M across 12 funding rounds to date. The company's 1st funding round was a Grant of $239.08K, raised on Aug 2016.
Ossium Health is engaged in bioengineering to enhance human health, vitality, and longevity. The company is recognized for creating a new paradigm in cell therapy by utilizing deceased donor transplant ecosystems to combat blood and immune system diseases. Solutions are developed for hematologic diseases, organ transplant rejection, and orthopedic applications. Partnerships are established with healthcare providers, life science companies, and organ procurement organizations to advance and deploy innovative cell therapies.
Ossium Health's top competitors include Orca Bio, Cellino and Adicet Bio.
Ossium Health offers Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.
Ossium Health has 9 investors. Key investors include HHS, Computer Programs Marketing Group, Vivo Capital, First Round Capital, and Manta Ray.
Ossium Health operates through Ossium Health, Inc..
